• Preparing for an FDA Audit? Learn the Best Behavior Practices and the Do’s and Don’ts
  • Preparing for an FDA Audit? Learn the Best Behavior Practices and the Do’s and Don’ts

    • Speaker : Charles H. Paul
    • Session Code : CPMAY2022
    • Date : 20th May 2022
    • Time : This Event is Over
    • Duration : 75 Mins



This webinar will begin by discussing and emphasizing the importance of truthfulness to the process – truthfulness in performing the job on a daily basis, truthfulness in completing the regulatory documentation that is so much a part of our regulatory lives, and finally in the context of this webinar, truthfulness when interacting with FDA inspectors.


A key component of this webinar is the discussion of the tricks and techniques that inspectors use to elicit information.  How you react and respond when they occur could impact your results.


Other key communications skills will be presented in the context of the inspection and interpersonal exchanges between inspectors and company associates being questioned.


We will complete the webinar by discussing how to handle, in the moment, adverse findings as they are identified by the inspector so as to not compound the issues and severity of the findings.


Following areas will be covered during the session:


  • Importance of truthfulness
  • Importance of knowledgeability and confidence
  • FDA Tricks to elicit information
  • Arguing and challenging
  • Behavior during the inspection
  • Importance and role of documentation
  • Effective communication skills
  • Being deceptive
  • Opinion versus fact
  • Phrases never to say
  • Handling adverse findings during the inspection


Why should you attend?


If you are in any regulated business - pharmaceuticals, medical devices, you will experience an inspection by the U.S. Food and Drug Administration (FDA).


According to the Food, Drug and Cosmetic Act, “Registered domestic drug establishments shall be inspected by the FDA at least once every two years.”


Depending upon the inspection type and the circumstance, inspections may occur more frequently.  The outcome of those inspections can have a grave significant impact upon your business even if you and your colleagues have done everything “right.” 


How you and others behave and interact with FDA inspectors can have an impact on the results reported.  Interacting with inspectors is not an natural behavior, effective techniques must be learned and mastered if those inspections are to have positive outcomes.


Who will benefit?

Compliance and Regulatory management professionals who spearhead the inspections and are responsible for compliance readiness in an organization, as well as training that should be building on-going training around this subject.

Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm.  Charles has been a regulatory consultant for over 20 years and has published numerous white papers on the subject.  The firm works with both domestic and international clients designing solutions for complex regulatory, training and documentation issues.

Write a review

Please login or register to review

Tags: FDA, Audit, Behavior, Practices, Do’s and Don’ts, Charles, Paul, May 2022, Webinar